✦ LIBER ✦

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

✍ Scribed by Alexopoulos, C G; Vaslamatzis, M; Hatzidimitriou, G

Book ID: 110002439
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 75 KB
Volume: 81
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6690652

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of hepatitis B virus genotype

Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B

✍ Long H. Nguyen; Nghiem B. Ha; Philip Vutien; Nghi B. Ha; Ruel T. Garcia; Huy N. 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 220 KB

Prevalence of hepatitis B virus DNA poly

Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B

✍ M. H. NGUYEN; R. T. GARCIA; H. N. TRINH; H. A. NGUYEN; K. K. NGUYEN; L. H. NGUYE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Efficacy of lamivudine in patients with

Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Correlation of hepatitis B virus, hepati

Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis

✍ N. Wagner; H. W. Rotthauwe; M. Becker; H. P. Dienes; T. Mertens; H. J. Födisch; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 628 KB

High prevalence of hepatitis B and hepat

High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies

✍ Jun Kang; Jeong Hyun Cho; Cheol Won Suh; Dae Ho Lee; Heung Bum Oh; Yong Hak Sohn 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 110 KB

Prevalence of hepatitis B, C, and D viru

Prevalence of hepatitis B, C, and D virus markers in yemeni patients with chronic liver disease

✍ Abdulkader M. El Guneid; Abdalla A. Gunaid; Ann Marie O'Neill; Nael I. Zureikat; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 1 views

## Abstract A serological survey for hepatitis B, C, and D markers was carried out in the Yemen Republic. Serum samples from 243 pregnant females, 294 male blood donors, and 108 patients with chronic liver disease were examined. Hepatitis B surface antigen (HBsAg) was found in 18.5% healthy individ